Fundraising FoxFastBack Bio
Raleigh, US · Founded 2020
Find your way into FastBack Bio
Sign up to see every warm intro you have to FastBack Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FastBack Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
Founders & leadership
Board
AS
ABRAHAM SURINDER MAINGIBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2020
▶$1.8MraisedNov 2020 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedNov 2020 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SHAILESH MAINGIPromoter
- ABRAHAM SURINDER MAINGIExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Nov 2020
- Incorporated
- Limited Liability Company, North Carolina, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does FastBack Bio do?
- Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
- How much funding has FastBack Bio raised?
- FastBack Bio has disclosed $1.8M raised across 1 round.
- Where is FastBack Bio headquartered?
- FastBack Bio is headquartered in Raleigh, US.